Erskine James, MD
Cardiovascular Disease · Macon, GANPI 1346326287
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $54,380 of the $66,798 with a category attached, or 81.4%. AstraZeneca accounts for 77.7% of it on its own, with 23 other manufacturers making up the rest. Reporting peaked in 2020 at $43,497 and has fallen 97.5% since, to $1,099 in 2025. Among cardiovascular disease clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 220 payments — averaging $303.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$52K
- Novartis$7K
- Abbott$3K
- Abiomed$2K
- Cvrx, Inc.$730
- Edwards Lifesciences$429
- plus $2K from 18 others
Across 23 payments — averaging $1156.15 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Livanova USA, Inc.$15K
- Novartis$8K
- AstraZeneca$4K
What the payments were for
- Speaking & faculty fees$54,38081%
- Travel & lodging$5,1608%
- Food & beverage$7,19411%
- Education$640%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 81 | $51,877 |
| Novartis | 15 | $7,063 |
| Abbott | 27 | $2,746 |
| Abiomed | 28 | $2,272 |
| Cvrx, Inc. | 13 | $730 |
| Edwards Lifesciences | 6 | $429 |
| Penumbra, Inc. | 2 | $192 |
| Heartflow, Inc. | 1 | $180 |
| Pfizer | 9 | $167 |
| Boston Scientific | 5 | $129 |
| Johnson & Johnson | 1 | $124 |
| Medtronic | 1 | $122 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 6 | $116 |
| Scpharmaceuticals Inc. | 1 | $110 |
| Angiodynamics, Inc. | 1 | $96 |
| Chiesi USA, Inc. | 5 | $84 |
| Alnylam Pharmaceuticals Inc. | 3 | $75 |
| Lantheus Medical Imaging, Inc. | 3 | $69 |
| Boehringer Ingelheim | 3 | $68 |
| Merck | 4 | $66 |
| E.r. Squibb & Sons, L.L.C. | 2 | $38 |
| Getinge USA Sales, LLC | 1 | $23 |
| Amgen | 1 | $13 |
| Osprey Medical Inc | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FARXIGA$51,070
- ENTRESTO$6,841
- Impella$1,321
- Mitra Clip system$1,240
- HeartMate 3 Left Ventricular Dev$604
- Barostim Neo System$435
- SAPIEN 3 Ultra RESILIA$259
- FFRct$180
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT$138
- Edwards SAPIEN 3 Transcatheter Heart Valve$138
- SPRAVATO$124
- CoreValve Evolut$122
- CARDIOMEMS$122
- Indigo System$121
- CardioMEMS HF System$118
- FUROSCIX$110
How this compares
$66,798 in reported general payments places this provider in the 95th percentile of 640 cardiovascular disease providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Warfarin Sodium | 17 | $93 |
Paid to pharmacies, not to this prescriber.
Other cardiovascular disease in Macon
- Julius ElmoreMacon$55K
- William KnopfMacon$43K
- Onajefe Nelson-TwakorMacon$23K
- Amy KingmanMacon$21K
- Narendra SinghJohns Creek$1.6M
- Hunter ChampionColumbus$1.5M
- Nicolas ChronosEatonton$912K
- Jaime BurkleGainesville$628K
- Joseph MillerAtlanta$573K
- Kashyap ChoksiThomasville$263K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.